Prelude Therapeutics Inc

NASDAQ:PRLD   11:47:31 AM EDT
4.47
-0.07 (-1.54%)
Earnings Announcements

Prelude Therapeutics Posts Q1 Loss Per Share $0.63

Published: 05/10/2022 12:21 GMT
Prelude Therapeutics Inc (PRLD) - Q1 Loss per Share $0.63.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.64

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.66

More details on our Analysts Page.